CrushSCI.com
Journal Selection & Manuscript Polishing Services
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING journal cover Medicine
Back to journal directory

Review Cycle Records

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Springer SCIE Non-OA
2026 Emerging Zone 12025 CAS Zone 1 TOP2025 JCR Q1
82.8Average days
81.5Median days
39Fastest days
130Longest days
6612025 publications

Paper Review Records

All Paper Review Records

18 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

85 days

Development and validation of a preoperative 18 F-PSMA-1007 PET/MR prognostic model for predicting biochemical recurrence in prostate cancer: a multicentre study

AuthorsJiajia Hu; Hangxing Chunyu; Yihong Yang; Yanyan Song; Chao Cheng; Hailang Tang; Xiaoyue Chen; Ran Cheng; Jun Dai; Hongping Meng; Changjing Zuo; Jun Zhao; Biao Li

Affiliations1. Department of Nuclear Medicine & Institute for Medical Imaging Technology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; 2. Department of Nuclear Medicine, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China; 3. Department of Biostatistics, Institute of Clinical Medicine, Shanghai Jiao-Tong University School of Medicine, Shanghai, China; 4. Department of Nuclear Medicine, Changhai Hospital, Navy Military Medical University, Shanghai, China; 5. Department of Ultrasound, Jiading North Hospital, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; 6. Department of Urology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

Source PDF DOI Publisher page
85 days

Tri-modal PSMA PET/CT-MRI-US fusion biopsy for clinically significant prostate cancer: a prospective paired diagnostic study

AuthorsChen Huang; Lichen Jin; Yizhang Sun; Menglin Wu; Xuefeng Zhang; Xiaofeng Xu; Xuefeng He; Feng Qiu; Ximing Wang; Lingchuan Guo; Renpeng Huang; Jihui Li; Shengming Deng; Yuxin Lin; Xuedong Wei; Bin Zhang; Yuhua Huang

Affiliations1. Department of Urology, The First Affiliated Hospital of Soochow University, Suzhou, China; 2. School of Computer Science and Technology, Nanjing Tech University, Nanjing, China; 3. Carbon Medical Device Ltd, Shenzhen, China; 4. Department of Radiology, The First Affiliated Hospital of Soochow University, Suzhou, China; 5. Department of Pathology, The First Affiliated Hospital of Soochow University, Suzhou, China; 6. Department of Nuclear Medicine, The First Affiliated Hospital of Soochow University, Suzhou, China

Source PDF DOI Publisher page
81 days

Correlation of 68 Ga-PSMA-11 PET/CT biodistribution with PSMA expression by immunohistochemistry in patients with HCC: A pilot prospective monocentric study

AuthorsL. Vetrone; E. Prosperi; E. Prosperi; F. Vasuri; A. Degiovanni; V. Allegri; P. Castellucci; L. Zanoni; Cristina Nanni; M. Renzulli; V. Lucidi; A. Cattabriga; C. Malizia; M. Ravaioli; M. Cescon; S. Fanti; A. Farolfi

Affiliations1. Nuclear Medicine, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy; 2. Department of Hepatobiliary Surgery and Liver Transplant, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy; 3. Pathology Unit, Santa Maria delle Croci Ravenna Hospital, Ravenna, Italy; 4. Pathology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy; 5. Department of Medical and Surgical Sciences (DIMEC), Bologna University, Bologna, Italy; 6. Nuclear Medicine, AST Pesaro Urbino, Pesaro, Italy; 7. Department of Radiology, IRCSS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy; 8. Nuclear Medicine, Alma Mater Studiorum University of Bologna, Bologna, Italy

Source PDF DOI Publisher page
50 days

Prognostic value and diagnostic performance of nectin-4-targeted [ 68 Ga]Ga-FZ-NR-1 PET/CT versus [ 18 F]FDG in recurrent or metastatic triple-negative breast cancer

AuthorsYe Li; Yuyun Sun; Li Sun; Dongliang Wang; Xiaoyu Pan; Xiaoping Xu; Shaoli Song

Affiliations1. Department of Nuclear Medicine, Fudan University Shanghai Cancer Center, Shanghai, China; 2. Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China; 3. Center for Biomedical Imaging, Fudan University, Shanghai, China; 4. Shanghai Engineering Research Center of Molecular Imaging Probes, Shanghai, China

Source PDF DOI Publisher page
69 days

Practices and barriers in PET/CT use for critically ill patients: an international survey

AuthorsCamilla Genovese; Jean-François Timsit; Michael Thy

Affiliations1. Department of Infectious Diseases, Ospedale Luigi Sacco, Milan, Italy; 2. Infectious Diseases Intensive Care Unit, Bichat-Claude Bernard University Hospital, AP-HP, Université Paris Cité, Paris, France; 3. Université Paris Cité and Université Sorbonne Paris Nord, INSERM, UMR1137, IAME, Paris, France; 4. UMR 1343, GEME, Pharmacologie et évaluation des thérapeutiques chez l’enfant et la femme enceinte, INSERM, Université Paris Cité, Paris, France

Source PDF DOI Publisher page
82 days

Radium-223 decreases PD-L1 expression in bone metastases: A study with [ 89 Zr]Zr-atezolizumab PET and immunohistological correlation

AuthorsSui Wai Ling; Anouk de Jong; Mark Gorris; Marcel Segbers; Laura Graven; Marjolein van Driel; Geert van Leenders; Khrystany Isebia; Marjolijn Lub – de Hooge; Paul Hamberg; Niven Mehra; Mandy van Brakel; Ronald de Wit; Reno Debets; Elisabeth de Vries; Tessa Brabander; Jolanda de Vries; Astrid van der Veldt

Affiliations1. Department of Radiology and Nuclear Medicine, Erasmus MC, Rotterdam, the Netherlands; 2. Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands; 3. Department of Medical BioSciences, Radboudumc, Nijmegen, the Netherlands; 4. Department of Internal Medicine, Erasmus MC, Rotterdam, the Netherlands; 5. Department of Pathology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands; 6. Department of Clinical Pharmacy and Pharmacology, UMC Groningen, University of Groningen, Groningen, the Netherlands; 7. Department of Internal Medicine, Franciscus Gasthuis and Vlietland Hospital, Rotterdam, the Netherlands; 8. Department of Medical Oncology, Radboud UMC, Nijmegen, the Netherlands; 9. Department of Medical Oncology, UMC Groningen, University of Groningen, Groningen, the Netherlands

Source PDF DOI Publisher page
74 days

Baseline serum carcinoembryonic antigen (CEA) is an independent prognostic biomarker for metastatic castration-resistant prostate cancer (mCRPC) patients receiving 177Lu-PSMA therapy

AuthorsEmilio Francesco Giunta; Irene Marini; Ilaria Grassi; Silvia Nicolini; Flavia Foca; Monica Celli; Paola Caroli; Anna Sarnelli; Nicole Brighi; Giuseppe Schepisi; Manuela Monti; Ugo De Giorgi; Cristian Lolli; Maddalena Sansovini

Affiliations1. Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Meldola, Italy; 2. Department of Nuclear Medicine, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Meldola, Italy; 3. Unit of Biostatistics and Clinical Trials, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Meldola, Italy; 4. Department of Experimental Medicine, University of Salento, Lecce, Italy

Source PDF DOI Publisher page
74 days

APOE4-dependent cholinergic/dopaminergic contributions to clinical symptoms across Alzheimer’s disease spectrum: A retrospective observational study

AuthorsSungwoo Kang; Seun Jeon; Donggeon Lee; Hanbi Lee; Su-Hee Jeon; Minsun Choi; Young-gun Lee; Na-Young Shin; Mijin Yun; Byoung Seok Ye

Affiliations1. Department of Neurology, Hanyang University College of Medicine, Seoul, Republic of Korea; 2. Metabolism-Dementia Research Institute, Yonsei University College of Medicine, Seoul, Republic of Korea; 3. Department of Neurology, Ilsan Paik Hospital, Inje University College of Medicine, Goyang, Republic of Korea; 4. Department of Radiology, Yonsei University College of Medicine, Seoul, Republic of Korea; 5. Department of Nuclear Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea; 6. Department of Neurology, Yonsei University College of Medicine, Seoul, Republic of Korea

Source PDF DOI Publisher page
58 days

The effects of use of medications on striatal dopamine transporter binding assessed by [ 123 I]I-FP-CIT SPECT in patients with Parkinson’s disease from the PPMI cohort

AuthorsAbdallah Nour Ali; Ilham Malik; Jan Booij; Youssef Chahid

Affiliations1. Department of Radiology and Nuclear Medicine, University of Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands; 2. Department of Pharmacy, University of Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands

Source PDF DOI Publisher page
78 days

Whole-body 18 F-FDG PET reveals glycemic state-dependent reorganization of directed inter-organ metabolic networks

AuthorsXuetong Tao; Runxiang Huang; Heng Jiang; Qian Sun; Yong Xiao; Zhan Li; Ning Ma; Xiaohua Lin; Guanghua Wen; Hairong Zheng; Dong Liang; Na Zhang; Mengjie Dong; Zhanli Hu

Affiliations1. Lauterbur Research Center for Biomedical Imaging, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China; 2. Key Laboratory of Biomedical Imaging Science and System, State Key Laboratory of Biomedical Imaging Science and System, Chinese Academy of Sciences, Shenzhen, China; 3. Research Center for Medical AI, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China; 4. Department of Nuclear Medicine, Peking University Shenzhen Hospital, Shenzhen, China; 5. Medical Imaging Center, Shenzhen Exit - Entry Frontier Inspection Station General Hospital, Shenzhen, China; 6. Department of Nuclear Medicine, Shenzhen Longhua District Central Hospital, Shenzhen, China

Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review96.4 days

Median77 days

Contact CrushSCI

Contact CrushSCI

Leave your contact details so we can discuss your manuscript, editing needs, and submission plan.

Selected service: Paper Editing Service

Or leave your contact details

WhatsApp, Telegram, WeChat, and email are all optional, but at least one is required. Once received, we will contact you as soon as possible.